As of 2025-10-30, the Relative Valuation of Cannara Biotech Inc (LOVE.CN) is (0.49) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 CAD, the upside of Cannara Biotech Inc based on Relative Valuation is -506.4%.
The range of the Relative Valuation is (0.62) - (0.32) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.6x - 40.2x | 37.4x |
| Forward P/E multiples | 15.8x - 17.0x | 16.4x |
| Fair Price | (0.62) - (0.32) | (0.49) |
| Upside | -617.8% - -362.7% | -506.4% |
| Date | P/E |